<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01858675</url>
  </required_header>
  <id_info>
    <org_study_id>2011-A01310-41</org_study_id>
    <nct_id>NCT01858675</nct_id>
  </id_info>
  <brief_title>Biomarkers Correlation With Volemia</brief_title>
  <acronym>ENVOL</acronym>
  <official_title>Predictive Value of Biomarkers on Volemia, Extra and Intra Vascular Varation and Hydroelectrolytic Disorders in Different ICU Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ThermoFisher Scientific Brahms Biomarkers France</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ThermoFisher Scientific Brahms Biomarkers France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the Biomarkers (pro adrenomedullin (MR
      proADM), pro arginin vasopressin (CT proAVP), pro atrial natriuretic peptid (MR proANP), Pro
      Endothelin) changes at Day 2, Day 5 and Day 7 of ICU admission are correlated with
      Intravascular volume assessed by Cr 51 on red blood cells (Day 2 and Day 7) and by I 125 on
      albumine Day 7. The correlation of these Biomarkers are also evaluted with other markers such
      as erythropoietin and catecholamines. 80 ICU patients are included.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Predictive value of biomarkers changes in Volemia variation</measure>
    <time_frame>at Day 2, Day 5 and Day 7 of ICU admission</time_frame>
    <description>Correlation with total blood volume(assessed by Cr 51) and biomarkers(Mr proADM, Mr proANP, CT proAVP and proendothelin)changes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Predictive value of biomarkers changes with efficient volemia, fluid managements and other Markers such erythropoietin</measure>
    <time_frame>at Day 2, Day 5 and Day 7 of ICU admission</time_frame>
    <description>Correlation with efficient volemia and Biomarkers ( Mr proADM, Mr proANP, CT proAVP and proendothelin)changes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predictive value of Biomarkers with APACHE II and SOFA score and Prognosis at ICU discharge</measure>
    <time_frame>at Day 2 , Day 5 and Day 7 of ICU admission and at discharge</time_frame>
    <description>Correlation of Biomarkers changes with APACHE II and SOFA score and Mortality at Day 2, Day 5 and Day 7 of their ICU admission and at ICU discharge.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Cerebral Hemorrhage</condition>
  <condition>Head Injury</condition>
  <condition>Non Traumatic Post Surgery</condition>
  <condition>Poly Trauma Patients Without Heart Failure</condition>
  <condition>Renal Insufficiency</condition>
  <arm_group>
    <arm_group_label>Biomarkers, total blood volume</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biomarkers, red blood cells and plasma assessment</intervention_name>
    <arm_group_label>Biomarkers, total blood volume</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  20 Cerebral Hemorrhage

          -  20 Head Injury

          -  20 post surgery non traumatic non neuro

          -  20 Polytrauma patients

        Exclusion Criteria:

          -  Heart failure NYHA III or IV

          -  Renal insufficiency creatinin clearance &lt; 30 ml/mn

          -  age &lt; 18 Y

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hôpital Bicêtre</name>
      <address>
        <city>Le Krémilin Bicêtre</city>
        <state>Ile de France</state>
        <zip>94 275</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 13, 2013</study_first_submitted>
  <study_first_submitted_qc>May 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2013</study_first_posted>
  <last_update_submitted>December 2, 2014</last_update_submitted>
  <last_update_submitted_qc>December 2, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ProADM</keyword>
  <keyword>ProANP</keyword>
  <keyword>proendothelin</keyword>
  <keyword>proAVP</keyword>
  <keyword>Cr 51</keyword>
  <keyword>Volemia</keyword>
  <keyword>fluid management</keyword>
  <keyword>ICU patients</keyword>
  <keyword>poly trauma patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Craniocerebral Trauma</mesh_term>
    <mesh_term>Cerebral Hemorrhage</mesh_term>
    <mesh_term>Multiple Trauma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

